Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Recombinant Vaccines Market, by Route of Administration
6.1 Introduction
6.2 Intramuscular and Subcutaneous Administration
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
6.3 Oral Administration
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
6.4 Other Routes of Administration
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
7. Global Recombinant Vaccines Market, by Type
7.1 Introduction
7.2 Subunit recombinant vaccines
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
7.3 Attenuated recombinant vaccines
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
7.4 Vector recombinant vaccines
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8. Global Recombinant Vaccines Market, by Disease
8.1 Introduction
8.2 Pneumococcal Disease
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8.3 Cancer
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8.4 Hepatitis B
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8.5 Influenza
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8.6 HPV (Human papillomavirus)
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8.7 DPT
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
8.8 Others
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9. Global Recombinant Vaccines Market, by End-User
9.1 Introduction
9.2 Hospitals & Clinics
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9.3 Pediatrics
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9.4 Adults
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9.5 Veterinary
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9.5.1 Poultry
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9.5.2 Livestock
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
9.5.3 Others
โข Market Estimates & Forecast, 2020โ2027
โข Market Estimates & Forecast, by Region/Country, 2020โ2027
10 Global Recombinant Vaccines Market, by Region
10.1 Introduction
10.2 Americas
โข Market Estimates & Forecast, by Region, 2020โ2027
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.2.1 North America
โข Market Estimates & Forecast, by Country, 2020โ2027
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.2.1.1 U.S.
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.2.1.2 Canada
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.2.2 South America
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3 Europe
โข Market Estimates & Forecast, by Region, 2020โ2027
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1 Western Europe
โข Market Estimates & Forecast, by Country, 2020โ2027
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1.1 Germany
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1.2 France
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1.3 U.K.
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1.4 Italy
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1.5 Spain
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.1.6 Rest of Western Europe
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.3.2 Eastern Europe
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4 Asia Pacific
โข Market Estimates & Forecast, by Country, 2020โ2027
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4.1 Japan
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4.2 China
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4.3 India
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4.4 Australia
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4.5 Republic of Korea
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.4.6 Rest of Asia Pacific
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5 The Middle East & Africa
โข Market Estimates & Forecast, by Region, 2020โ2027
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5.1 United Arab Emirates
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5.2 Saudi Arabia
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5.3 Oman
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5.4 Kuwait
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5.5 Qatar
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
10.5.6 Rest of the Middle East & Africa
โข Market Estimates & Forecast, by Type, 2020โ2027
โข Market Estimates & Forecast, by Disease, 2020โ2027
โข Market Estimates & Forecast, by End-User, 2020โ2027
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Astellas Pharma Inc
12.1.1 Company Overview
12.1.2 Route of Administration Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 CSL Limited
12.2.1 Company Overview
12.2.2 Route of Administration Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Emergent BioSolutions, Inc.
12.3.1 Company Overview
12.3.2 Route of Administration Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 GlaxoSmithKline
12.4.1 Company Overview
12.4.2 Route of Administration/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Johnson & Johnson (U.S.)
12.5.1 Company Overview
12.5.2 Route of Administration Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Mitsubishi Tanabe Pharma Corporation
12.6.1 Company Overview
12.6.2 Route of Administration Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Merck & Co., Inc.
12.7.1 Overview
12.7.2 Route of Administration Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Pfizer, Inc..
12.8.1 Overview
12.8.2 Route of Administration Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Sanofi Pasteur SA
12.9.1 Overview
12.9.2 Route of Administration Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Serum Institute of India Pvt. Ltd
12.10.1 Overview
12.10.2 Route of Administration Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Bavarian Nordic
12.11.1 Overview
12.11.2 Route of Administration Overview
12.11.3 Financials
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 Mitsubishi Tanabe Pharma Corporation
12.12.1 Overview
12.12.2 Route of Administration Overview
12.12.3 Financials
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.13 Daiichi Sankyo
12.13.1 Overview
12.13.2 Route of Administration Overview
12.13.3 Financials
12.13.4 Key Developments
12.13.5 SWOT Analysis
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Recombinant Vaccines Industry Synopsis, 2020โ2027
Table 2 Global Recombinant Vaccines Market Estimates and Forecast, 2020โ2027, (USD Million)
Table 3 Global Recombinant Vaccines Market by Region, 2020โ2027, (USD Million)
Table 5 Global Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 6 Global Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 7 Global Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 8 North America Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 9 North America Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 10 North America Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 11 US Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 12 US Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 13 US Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 14 Canada Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 15 Million)
Table 16 Canada Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 17 Canada Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 18 South America Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 19 South America Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 20 South America Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 21 Europe Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 22 Europe Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 23 Europe Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 24 Western Europe Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 25 Western Europe Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 26 Western Europe Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 27 Eastern Europe Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 28 Eastern Europe Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 29 Eastern Europe Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 30 Asia Pacific Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 31 Asia Pacific Recombinant Vaccines Market by Disease, 2020โ2027, (USD Million)
Table 32 Asia Pacific Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
Table 33 Middle East & Africa Recombinant Vaccines Market by Type, 2020โ2027, (USD Million)
Table 34 Middle East & Africa Recombinant Vaccines Market by End-Users, 2020โ2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Recombinant Vaccines Market
Figure 3 Segmentation Market Dynamics for Recombinant Vaccines Market
Figure 4 Global Recombinant Vaccines Market Share, by Type 2020
Figure 5 Global Recombinant Vaccines Market Share, by End-Users, 2020
Figure 6 Global Recombinant Vaccines Market Share, by Region, 2020
Figure 7 North America Recombinant Vaccines Market Share, by Country, 2020
Figure 8 Europe Recombinant Vaccines Market Share, by Country, 2020
Figure 9 Asia Pacific Recombinant Vaccines Market Share, by Country, 2020
Figure 10 Middle East & Africa Recombinant Vaccines Market Share, by Country, 2020
Figure 11 Global Recombinant Vaccines Market: Company Share Analysis, 2020 (%)
Figure 12 Astellas Pharma Inc: Key Financials
Figure 13 Astellas Pharma Inc: Segmental Revenue
Figure 14 Astellas Pharma Inc: Geographical Revenue
Figure 15 Emergent BioSolutions, Inc.. Key Financials
Figure 16 Emergent BioSolutions, Inc.: Segmental Revenue
Figure 17 Emergent BioSolutions, Inc.: Geographical Revenue
Figure 18 Pfizer, Inc.. : Key Financials
Figure 19 Pfizer, Inc.. : Segmental Revenue
Figure 20 Pfizer, Inc.. : Geographical Revenue
Figure 21 GlaxoSmithKline: Key Financials
Figure 22 GlaxoSmithKline: Segmental Revenue
Figure 23 GlaxoSmithKline: Geographical Revenue
Figure 24 Mitsubishi Tanabe Pharma Corporation : Key Financials
Figure 25 Mitsubishi Tanabe Pharma Corporation : Segmental Revenue
Figure 26 Mitsubishi Tanabe Pharma Corporation . Geographical Revenue
Figure 29 Bavarian Nordic. Key Financials
Figure 30 Bavarian Nordic. Segmental Revenue
Figure 31 Bavarian Nordic. Geographical Revenue